NCT03200860View on ClinicalTrials.gov

Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

September 18, 2019

Study Completion Date

September 18, 2019

Conditions
Heart Failure AcuteHeart Failure，CongestiveHeart Failure; With Decompensation
Interventions
DRUG

Empagliflozin 10 MG

10 mg daily, oral, 30 days

DRUG

Placebo Oral Tablet

Matching Placebo, 10 mg daily, oral, 30 days

Trial Locations (5)

Unknown

TREANT Zorggroep, Emmen

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

ISALA Klinieken, Zwolle

Antonius Ziekenhuis, Sneek

9700RB

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT03200860 - Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure | Biotech Hunter | Biotech Hunter